It has been shown experimentally that the cornea is capable of supporting two types of hypersensitivity phenomena.1 The first type appears to be mediated by immunologically competent mononuclear cells, the second type by circulating antibodies.
When a soluble protein antigen is used to sensitize the cornea, the cellular-mediated response is manifest grossly by a transient dilatation of the circumlimbal vessels and a diffuse ground-glass opacification of the cornea. In contrast, the antibody-mediated corneal hypersensitivity reaction presents as a grossly discernible, white ring of opacification. The ring is composed of antigen-antibody complexes and inflammatory cells and is accompanied by dilatation of perilimbal vessels and corneal neovascularization.
Like the experimentally produced types of corneal hypersensitivity, the rejection of homologous and heterologous corneal grafts is thought to be immunologic in nature.2-5 However, though circulating antibodies are often implicated in the rejection response, a ring reaction has never been reported.
ELLIOTT JH, LEIBOWITZ HM. Corneal Immune Rings Associated With Heterograft Rejection. Arch Ophthalmol. 1965;73(4):519–527. doi:10.1001/archopht.1965.00970030521015
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: